Association between single nucleotide polymorphism ofPD-L1gene and non-small cell lung cancer susceptibility in a Chinese population

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

(2010) Shiro Fujita et al.   BMC Medical Genetics

Tumor progression by immune evasion in melanoma

(2010) Mohammed Kashani-Sabet   CANCER

Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors

(2010) Sarah M. Rausch et al.   CANCER

In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors

(2010) Céline Berthon et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A 3'-Untranslated Region Polymorphism in IGF1 Predicts Survival of Non-Small Cell Lung Cancer in a Chinese Population

(2010) M. Zhang et al.   CLINICAL CANCER RESEARCH

The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients

(2010) Seong-Jang Kim et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Lung Cancer Genomic Signatures

(2010) M. Teresa Agulló-Ortuño et al.   Journal of Thoracic Oncology

High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

(2010) Chuan-Yong Mu et al.   MEDICAL ONCOLOGY

Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes

(2009) Ruo-Chia Tseng et al.   CANCER

MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer

(2009) Ning Sun et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Childhood Exposure to Secondhand Smoke and Functional Mannose Binding Lectin Polymorphisms Are Associated with Increased Lung Cancer Risk

(2009) S. E. Olivo-Marston et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences

(2009) Maria N. Timofeeva et al.   CARCINOGENESIS

Association of XPD Polymorphisms with Severe Toxicity in Non-Small Cell Lung Cancer Patients in a Chinese Population

(2009) W. Wu et al.   CLINICAL CANCER RESEARCH

DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non–Small-Cell Lung Cancer

(2009) Aristea Kalikaki et al.   Clinical Lung Cancer

7th Revision of the Declaration of Helsinki: Good News for the Transparency of Clinical Trials

(2009) Karmela Krleža-Jerić et al.   CROATIAN MEDICAL JOURNAL

Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China

(2009) Min Shen et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Programmed Death Ligand 1 (PD-L1) Gene Variants Contribute to Autoimmune Addison’s Disease and Graves’ Disease Susceptibility

(2009) Anna L. Mitchell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells

(2008) T. Azuma et al.   BLOOD

Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1–IgV

(2008) C. Zhang et al.   CYTOTHERAPY

Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients.

(2008) Mina Hayashi et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Non-small cell lung cancer staging: proposed revisions to the TNM system

(2008) Bryan J. Schneider   CANCER IMAGING